Description and Brand Names
Drug information provided by: IBM Micromedex
US Brand Name
- Stivarga
Descriptions
Regorafenib is used to treat metastatic cancer (cancer that has spread) of the colon and rectum. It is used in patients who have already been treated with other cancer medicines that did not work well. Regorafenib prevents the growth of tumors.
Regorafenib is also used to treat metastatic gastrointestinal stromal tumors (GIST) in patients who have already received other medicines that did not work well. GIST is a rare cancer that affects the stomach, bowel, or esophagus. This medicine is used to treat a type of liver cancer called hepatocellular cancer (HCC) in patients who have already been treated with sorafenib.
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2019
Copyright © 2019 IBM Watson Health. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.